Summary
This 8-K filing from HCA Healthcare, Inc. (HCA) on April 7, 2010, reports on a significant amendment to its existing Credit Agreement, dated November 17, 2006. The primary focus is the "Extension Amendment No. 1," which, among other provisions, extends the maturity date for $2.0 billion of the Company's tranche B term loans to March 31, 2017. This extension provides HCA with greater financial flexibility and a longer runway for a substantial portion of its debt. Additionally, the amendment adjusts the interest margins for these extended loans, increasing the ABR margin to 2.25% and the LIBOR margin to 3.25%. While this represents an increase in borrowing costs for this specific tranche of debt, it is likely a consequence of securing a longer maturity period. Importantly, all other loans, commitments, and letters of credit under the Credit Agreement remain unaffected by this amendment.
Key Highlights
- 1HCA Healthcare entered into Extension Amendment No. 1 to its Credit Agreement on April 6, 2010.
- 2The amendment extends the maturity date of $2.0 billion of tranche B term loans to March 31, 2017.
- 3This extension provides a longer-term financing solution for a significant portion of HCA's debt.
- 4The ABR margin for the extended term loans increased to 2.25%.
- 5The LIBOR margin for the extended term loans increased to 3.25%.
- 6Maturity dates, margins, and commitments for other outstanding loans remain unchanged.
- 7The amendment was entered into by HCA Inc., its European Subsidiary Borrower, guarantors, lenders, and Bank of America, N.A. as administrative agent.